Vertex Boosts Revenue Forecast on Back of Cystic Fibrosis Franchise Growth

Seeking AlphaAug 2 11:24 ET

Rodman & Renshaw Initiates CRISPR Therapeutics at Buy With $90 Price Target

MT NewswiresAug 2 07:30 ET · Ratings

CRISPR Therapeutics AG (CRSP): Ark Invest Is Bullish on This Stock Right Now

Yahoo FinanceAug 1 12:21 ET

CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to Note

Yahoo FinanceJul 26 17:50 ET

Actinium Wins FDA Nod to Conduct Clinical Trial for Radiotherapy

Seeking AlphaJul 25 10:29 ET

CRISPR Therapeutics Stock Is Approaching Its 52-Week Low

TipRanksJul 24 05:53 ET